Business
Univercells Technologies Debuts the scale-X™ Nitro Controller to Expand Access to Large-Scale Viral and Advanced Therapy Manufacturing
NIVELLES, Belgium, May 07, 2025--Univercells Technologies, a Donaldson Life Sciences business and global provider of bioprocessing solutions, announced the launch of the scale-X™ nitro controller, the latest addition to its scale-X fixed-bed bioreactor portfolio. Designed to operate both the 200 and 600 m² scale-X nitro bioreactors, the new controller becomes part of the scale-X platform for a cost-effective, low-footprint and user-friendly solution for large-scale viral and advanced therapy man
About this update from Donaldson Company, Inc.
[{"type":"image","alt":"The scale-X™ nitro controller delivers high productivity while enabling rapid scalability from R&D to commercial production in just eight months.","displaySize":"","headline":null,"caption":"The scale-X™ nitro controller delivers high productivity while enabling rapid scalability from R&D to commercial production in just eight months.","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":320,"url":"https://media.zenfs.com/en/business-wire.com/5ad85c848d8bd40925b799d4df9c52ef"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/sQGoslSKitCeUo2IS4CPrA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTY0MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/5ad85c848d8bd40925b799d4df9c52ef","width":480,"height":320}},"lazy":false},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/340fe5d094af65babd68c310b4f05adf"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/0fASJzeqfgpsD0WSsT3mng--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/340fe5d094af65babd68c310b4f05adf","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/fie9kE1HdMf4NRucBpfHhw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/340fe5d094af65babd68c310b4f05adf","width":1024,"height":512}}},{"type":"text","content":"NIVELLES, Belgium, May 07, 2025--(BUSINESS WIRE)--Univercells Technologies, a Donaldson Life Sciences business and global provider of bioprocessing solutions, announced the launch of the scale-X™ nitro controller, the latest addition to its scale-X fixed-bed bioreactor portfolio. Designed to operate both the 200 and 600 m² scale-X nitro bioreactors, the new controller becomes part of the scale-X platform for a cost-effective, low-footprint and user-friendly solution for large-scale viral and advanced therapy manufacturing. The controller delivers high productivity while enabling rapid scalability from R&D to commercial production in just eight months.","length":663,"tagName":"p"},{"type":"text","content":"The new controller complements the existing NevoLine™ bioreactor platform by providing an alternative for devel...